25 March 2021 in Proceedings of the National Academy of Sciences
CD4+Foxp3+ regulatory T (Treg) cells are central modulators of autoimmune diseases. However, the timing and location of Treg cell–mediated suppression of tissue-specific autoimmunity remain undefined. Here, we addressed these questions by investigating the role of tumor necrosis factor (TNF) receptor 2 (TNFR2) signaling in Treg cells during experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis. We found that TNFR2-expressing Treg cells were critical to suppress EAE at peak disease in the central nervous system but had no impact on T cell priming in lymphoid tissues at disease onset. Mechanistically, TNFR2 signaling maintained functional Treg cells with sustained expression of CTLA-4 and Blimp-1, allowing active suppression of pathogenic T cells in the inflamed central nervous system. This late effect of Treg cells was further confirmed by treating mice with TNF and TNFR2 agonists and antagonists. Our findings show that endogenous Treg cells specifically suppress an autoimmune disease by acting in the target tissue during overt inflammation. Moreover, they bring a mechanistic insight to some of the adverse effects of anti-TNF therapy in patients. Significance Regulatory T (Treg) cells have been highlighted for their central function in limiting the severity of autoimmune diseases such as multiple sclerosis (MS). To date, the anatomical location and timing of this Treg cell–mediated suppression are unknown. In this report, in a mouse model of MS, we demonstrate that Treg cells inhibit the pathogenic process directly in the central nervous system during established disease, rather than in the presymptomatic phase. This protective function requires the surface expression of TNF receptor 2 by Treg cells, as its genetic ablation or antibody-mediated blockade worsens disease symptoms. Our data reveal a unique function of Treg cells in autoimmunity and highlight TNFR2 as a promising therapeutic target.
3 October 2025 in Science Advances
Foxp3 + regulatory T cells (T regs ) reside in both lymphoid and nonlymphoid organs, where they play a crucial role in immune tolerance and tissue homeostasis. In mice, T regs begin colonizing these tissues shortly after birth, contributing to long-term immune response regulation therein. However, the kinetics of T reg generation across different tissues remains unclear. Here, we investigate T reg ontogeny from birth to adulthood in various tissues. In lymphoid organs, the adult T reg pool is continuously replenished with cells generated at different ages. In contrast, the skin retains a large fraction of T regs that colonize the tissue during the neonatal period, with minimal turnover in adulthood. The liver, lungs, and colon exhibit intermediate T reg renewal dynamics. Notably, neonatal T regs that persist into adulthood display a more activated phenotype and express markers associated with tissue-resident T regs and type 2 immunity. Our findings reveal tissue-specific differences in T reg generation kinetics and highlight a major phenotypic shift between neonatal and adult-derived T regs .